Stock Movers: Novo Nordisk Bid, Legrand Sales Slowdown, Zalando Rises

Novo Nordisk's Metsera Bid and Drug Pricing

• 💡 A judge denied Pfizer's request to block Novo Nordisk's $10 billion bid for obesity startup Metsera, suggesting a potential bidding war.
• 🎯 Novo Nordisk shares also saw a boost from news of a potential deal with the Trump administration regarding weight loss drug pricing.
• 📈 These positive developments helped to offset recent losses after Novo Nordisk trimmed its forecast for the fourth time this year.

Legrand's Sales Miss and Data Center Slowdown

• 📉 French industrial company Legrand experienced a stock drop as its third-quarter sales missed expectations.
• ⚠️ The slowdown is attributed to a cooling demand in the data center infrastructure market, a key growth driver for the company.
• 📊 Analysts suggest that Legrand maintaining its guidance implies a slowdown in fourth-quarter sales growth, with some calling it a "reality check."
• ⚡ The weakness in data centers poses a risk for other companies in the sector, such as Schneider Electric.

Zalando's Strong Sales and Share Buyback

• 📈 Online retailer Zalando's shares rose after reporting third-quarter sales that exceeded expectations.
• 💰 The company also announced a 100 million euro share buyback program, which contributed to investor confidence.
• 🚀 The positive results for Zalando are seen as good news for the wider online retail sector, which has faced challenges from competition and softer consumer sentiment.